|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
These three high-yield dividend stocks won't keep you awake at night.
One of these numbers represents an all-time high for the biotech.
Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 -- it failed.